|
Diabetes Care, Vol 23, Issue 12 1835-1839, Copyright © 2000 by American Diabetes Association
Association between C-reactive protein and features of the metabolic syndrome: a population-based study
M Frohlich, A Imhof, G Berg, WL Hutchinson, MB Pepys, H Boeing, R Muche, H Brenner and W Koenig
Department of Internal Medicine II, University of Ulm Medical Center, Germany. margit.froehlich@medizin.uni-ulm.de
OBJECTIVE: To assess the association of circulating levels of C-reactive
protein, a sensitive systemic marker of inflammation, with different
components of the metabolic syndrome. RESEARCH DESIGN AND METHODS: Total
cholesterol (TC), HDL cholesterol, triglycerides, uric acid, BMI , and
prevalence of diabetes and hypertension were assessed in 747 men and 956
women aged 18-89 years who were participating in the population-based
National Health and Nutrition Survey, which was carried out in former West
Germany in 1987-1988. RESULTS: There was a statistically significant
positive crude correlation between C-reactive protein and TC (R = 0.19), TG
(R = 0.29), BMI (R = 0.32), glucose (R = 0.11), and uric acid (R = 0.14)
(all P < 0.0001). A negative correlation was found between C-reactive
protein and HDL cholesterol (R = 0.13, P < 0.0001). The age-adjusted
geometric means of C-reactive protein concentrations in subjects grouped
according to the presence of 0-1, 2-3, and > or =4 features of the
metabolic syndrome were 1.11, 1.27, and 2.16 mg/l, respectively, with a
statistically highly significant trend (P < 0.0001). CONCLUSIONS: The
data suggest that a variety of features of the metabolic syndrome are
associated with a systemic inflammatory response.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
P. G. Wilson, J. C. Thompson, N. R. Webb, F. C. de Beer, V. L. King, and L. R. Tannock
Serum Amyloid A, but Not C-Reactive Protein, Stimulates Vascular Proteoglycan Synthesis in a Pro-Atherogenic Manner
Am. J. Pathol.,
December 1, 2008;
173(6):
1902 - 1910.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Suzuki, R. Katz, N. S. Jenny, N. A. Zakai, M. M. LeWinter, J. I. Barzilay, and M. Cushman
Metabolic Syndrome, Inflammation, and Incident Heart Failure in the Elderly: The Cardiovascular Health Study
Circ Heart Fail,
November 1, 2008;
1(4):
242 - 248.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. E. Laaksonen, L. Niskanen, K. Nyyssonen, T. A. Lakka, J. A. Laukkanen, and J. T. Salonen
Dyslipidaemia as a predictor of hypertension in middle-aged men
Eur. Heart J.,
October 2, 2008;
29(20):
2561 - 2568.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-F. Mauger, J. Levesque, M.-E. Paradis, N. Bergeron, A. Tchernof, P. Couture, and B. Lamarche
Intravascular Kinetics of C-Reactive Protein and Their Relationships with Features of the Metabolic Syndrome
J. Clin. Endocrinol. Metab.,
August 1, 2008;
93(8):
3158 - 3164.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Krishnan, K. Svendsen, J. D. Neaton, G. Grandits, L. H. Kuller, and for the MRFIT Research Group
Long-term Cardiovascular Mortality Among Middle-aged Men With Gout
Arch Intern Med,
May 26, 2008;
168(10):
1104 - 1110.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Tasali and M. S. M. Ip
Obstructive Sleep Apnea and Metabolic Syndrome: Alterations in Glucose Metabolism and Inflammation
Proceedings of the ATS,
February 15, 2008;
5(2):
207 - 217.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Anan, T. Masaki, Y. Umeno, T. Iwao, H. Yonemochi, N. Eshima, T. Saikawa, and H. Yoshimatsu
Correlations of high-sensitivity C-reactive protein and atherosclerosis in Japanese type 2 diabetic patients
Eur. J. Endocrinol.,
September 1, 2007;
157(3):
311 - 317.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Muscari, S. Antonelli, G. Bianchi, G. Cavrini, S. Dapporto, A. Ligabue, C. Ludovico, D. Magalotti, G. Poggiopollini, M. Zoli, et al.
Serum C3 Is a Stronger Inflammatory Marker of Insulin Resistance Than C-Reactive Protein, Leukocyte Count, and Erythrocyte Sedimentation Rate: Comparison study in an elderly population
Diabetes Care,
September 1, 2007;
30(9):
2362 - 2368.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Liu, L. Tinker, Y. Song, N. Rifai, D. E. Bonds, N. R. Cook, G. Heiss, B. V. Howard, G. S. Hotamisligil, F. B. Hu, et al.
A Prospective Study of Inflammatory Cytokines and Diabetes Mellitus in a Multiethnic Cohort of Postmenopausal Women
Arch Intern Med,
August 13, 2007;
167(15):
1676 - 1685.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Yuan, X. Chen, Q. Ma, J. Qiao, R. Li, X. Li, S. Li, J. Tang, L. Zhou, H. Song, et al.
C-reactive protein inhibits adiponectin gene expression and secretion in 3T3-L1 adipocytes
J. Endocrinol.,
August 1, 2007;
194(2):
275 - 281.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Porrini, M. D. Gomez, A. Alvarez, M. Cobo, J. M. Gonzalez-Posada, L. Perez, L. Hortal, J. J. Garcia, M. Dolores Checa, A. Morales, et al.
Glycated haemoglobin levels are related to chronic subclinical inflammation in renal transplant recipients without pre-existing or new onset diabetes
Nephrol. Dial. Transplant.,
July 1, 2007;
22(7):
1994 - 1999.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Ye, Z. Yu, H. Li, O. H. Franco, Y. Liu, and X. Lin
Distributions of C-Reactive Protein and its Association With Metabolic Syndrome in Middle-Aged and Older Chinese People
J. Am. Coll. Cardiol.,
May 1, 2007;
49(17):
1798 - 1805.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. de Rekeneire, R. Peila, J. Ding, L. H. Colbert, M. Visser, R. I. Shorr, S. B. Kritchevsky, L. H. Kuller, E. S. Strotmeyer, A. V. Schwartz, et al.
Diabetes, Hyperglycemia, and Inflammation in Older Individuals: The Health, Aging and Body Composition study
Diabetes Care,
August 1, 2006;
29(8):
1902 - 1908.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Ruggiero, A. Cherubini, A. Ble, A. J.G. Bos, M. Maggio, V. D. Dixit, F. Lauretani, S. Bandinelli, U. Senin, and L. Ferrucci
Uric acid and inflammatory markers
Eur. Heart J.,
May 2, 2006;
27(10):
1174 - 1181.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Scarpelli, M. Cardellini, F. Andreozzi, E. Laratta, M. L. Hribal, M. A. Marini, V. Tassi, R. Lauro, F. Perticone, and G. Sesti
Variants of the interleukin-10 promoter gene are associated with obesity and insulin resistance but not type 2 diabetes in caucasian italian subjects.
Diabetes,
May 1, 2006;
55(5):
1529 - 1533.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Poirier, T. D. Giles, G. A. Bray, Y. Hong, J. S. Stern, F. X. Pi-Sunyer, and R. H. Eckel
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss: An Update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease From the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism
Circulation,
February 14, 2006;
113(6):
898 - 918.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. F. Navarro and C. Mora
Role of inflammation in diabetic complications
Nephrol. Dial. Transplant.,
December 1, 2005;
20(12):
2601 - 2604.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Koyama, T. Shoji, H. Yokoyama, K. Motoyama, K. Mori, S. Fukumoto, M. Emoto, T. Shoji, H. Tamei, H. Matsuki, et al.
Plasma Level of Endogenous Secretory RAGE Is Associated With Components of the Metabolic Syndrome and Atherosclerosis
Arterioscler. Thromb. Vasc. Biol.,
December 1, 2005;
25(12):
2587 - 2593.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Mittermayer, J. Pleiner, G. Schaller, S. Zorn, K. Namiranian, S. Kapiotis, G. Bartel, M. Wolfrum, M. Brugel, J. Thiery, et al.
Tetrahydrobiopterin corrects Escherichia coli endotoxin-induced endothelial dysfunction
Am J Physiol Heart Circ Physiol,
October 1, 2005;
289(4):
H1752 - H1757.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. G. Best, Y. Zhang, E. T. Lee, J.-L. Yeh, L. Cowan, V. Palmieri, M. Roman, R. B. Devereux, R. R. Fabsitz, R. P. Tracy, et al.
C-Reactive Protein as a Predictor of Cardiovascular Risk in a Population With a High Prevalence of Diabetes: The Strong Heart Study
Circulation,
August 30, 2005;
112(9):
1289 - 1295.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. R. Tannock, K. D. O'Brien, R. H. Knopp, B. Retzlaff, B. Fish, M. H. Wener, S. E. Kahn, and A. Chait
Cholesterol Feeding Increases C-Reactive Protein and Serum Amyloid A Levels in Lean Insulin-Sensitive Subjects
Circulation,
June 14, 2005;
111(23):
3058 - 3062.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Basu, A. Larsson, J. Vessby, B. Vessby, and C. Berne
Type 1 Diabetes Is Associated With Increased Cyclooxygenase- and Cytokine-Mediated Inflammation
Diabetes Care,
June 1, 2005;
28(6):
1371 - 1375.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Song, P. M. Ridker, J. E. Manson, N. R. Cook, J. E. Buring, and S. Liu
Magnesium Intake, C-Reactive Protein, and the Prevalence of Metabolic Syndrome in Middle-Aged and Older U.S. Women
Diabetes Care,
June 1, 2005;
28(6):
1438 - 1444.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T Sturmer, E Raum, M Buchner, K Gebhardt, M Schiltenwolf, W Richter, and H Brenner
Pain and high sensitivity C reactive protein in patients with chronic low back pain and acute sciatic pain
Ann Rheum Dis,
June 1, 2005;
64(6):
921 - 925.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Hung, B. M. McQuillan, C. M. L. Chapman, P. L. Thompson, and J. P. Beilby
Elevated Interleukin-18 Levels Are Associated With the Metabolic Syndrome Independent of Obesity and Insulin Resistance
Arterioscler. Thromb. Vasc. Biol.,
June 1, 2005;
25(6):
1268 - 1273.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. J. Gersh, T. S.M. Tsang, M. E. Barnes, and J. B. Seward
The changing epidemiology of non-valvular atrial fibrillation: the role of novel risk factors
Eur. Heart J. Suppl.,
May 1, 2005;
7(suppl_C):
C5 - C11.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. S. Ford, U. A. Ajani, and A. H. Mokdad
The Metabolic Syndrome and Concentrations of C-Reactive Protein Among U.S. Youth
Diabetes Care,
April 1, 2005;
28(4):
878 - 881.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Stuveling, S. J. L. Bakker, H. L. Hillege, P. E. de Jong, R. O. B. Gans, and D. de Zeeuw
Biochemical risk markers: a novel area for better prediction of renal risk?
Nephrol. Dial. Transplant.,
March 1, 2005;
20(3):
497 - 508.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. O. Talbott, J. V. Zborowski, M. Y. Boudreaux, K. P. McHugh-Pemu, K. Sutton-Tyrrell, and D. S. Guzick
The Relationship between C-Reactive Protein and Carotid Intima-Media Wall Thickness in Middle-Aged Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab.,
December 1, 2004;
89(12):
6061 - 6067.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. You, A. S. Ryan, and B. J. Nicklas
The Metabolic Syndrome in Obese Postmenopausal Women: Relationship to Body Composition, Visceral Fat, and Inflammation
J. Clin. Endocrinol. Metab.,
November 1, 2004;
89(11):
5517 - 5522.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kaushal, A. H. Heald, K. W. Siddals, M. S. Sandhu, D. B. Dunger, J. M. Gibson, and N. J. Wareham
The Impact of Abnormalities in IGF and Inflammatory Systems on the Metabolic Syndrome
Diabetes Care,
November 1, 2004;
27(11):
2682 - 2688.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Vishnevetsky, V. A Kiyanista, and P. J Gandhi
CD40 Ligand: A Novel Target in the Fight Against Cardiovascular Disease
Ann. Pharmacother.,
September 1, 2004;
38(9):
1500 - 1508.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. K. Rutter, J. B. Meigs, L. M. Sullivan, R. B. D'Agostino Sr, and P. W.F. Wilson
C-Reactive Protein, the Metabolic Syndrome, and Prediction of Cardiovascular Events in the Framingham Offspring Study
Circulation,
July 27, 2004;
110(4):
380 - 385.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. S. Ryan and B. J. Nicklas
Reductions in Plasma Cytokine Levels With Weight Loss Improve Insulin Sensitivity in Overweight and Obese Postmenopausal Women
Diabetes Care,
July 1, 2004;
27(7):
1699 - 1705.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Greenfield, K. Samaras, A. B. Jenkins, P. J. Kelly, T. D. Spector, J. R. Gallimore, M. B. Pepys, and L. V. Campbell
Obesity Is an Important Determinant of Baseline Serum C-Reactive Protein Concentration in Monozygotic Twins, Independent of Genetic Influences
Circulation,
June 22, 2004;
109(24):
3022 - 3028.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P Z Hrycaj, T Sturmer, H Brenner, W Koenig, and K P Gunther
Systemic inflammation in osteoarthritis * Authors' reply
Ann Rheum Dis,
June 1, 2004;
63(6):
750 - 751.
[Full Text]
|
 |
|

|
 |

|
 |
 
H. S. Lett, J. A. Blumenthal, M. A. Babyak, A. Sherwood, T. Strauman, C. Robins, and M. F. Newman
Depression as a Risk Factor for Coronary Artery Disease: Evidence, Mechanisms, and Treatment
Psychosom Med,
May 1, 2004;
66(3):
305 - 315.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Helmersson, B. Vessby, A. Larsson, and S. Basu
Association of Type 2 Diabetes With Cyclooxygenase-Mediated Inflammation and Oxidative Stress in an Elderly Population
Circulation,
April 13, 2004;
109(14):
1729 - 1734.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Austin, K. L. Edwards, M. J. McNeely, W. L. Chandler, D. L. Leonetti, P. J. Talmud, S. E. Humphries, and W. Y. Fujimoto
Heritability of Multivariate Factors of the Metabolic Syndrome in Nondiabetic Japanese Americans
Diabetes,
April 1, 2004;
53(4):
1166 - 1169.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Pickup
Inflammation and Activated Innate Immunity in the Pathogenesis of Type 2 Diabetes
Diabetes Care,
March 1, 2004;
27(3):
813 - 823.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Fonseca, C. Desouza, S. Asnani, and I. Jialal
Nontraditional Risk Factors for Cardiovascular Disease in Diabetes
Endocr. Rev.,
February 1, 2004;
25(1):
153 - 175.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T Sturmer, H Brenner, W Koenig, and K-P Gunther
Severity and extent of osteoarthritis and low grade systemic inflammation as assessed by high sensitivity C reactive protein
Ann Rheum Dis,
February 1, 2004;
63(2):
200 - 205.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Wolf, J. Sauk, A. Shah, K. Vossen Smirnakis, R. Jimenez-Kimble, J. L. Ecker, and R. Thadhani
Inflammation and Glucose Intolerance: A prospective study of gestational diabetes mellitus
Diabetes Care,
January 1, 2004;
27(1):
21 - 27.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. C.B. Tan, W.-S. Chow, S. Tam, R. Bucala, and J. Betteridge
Association Between Acute-Phase Reactants and Advanced Glycation End Products in Type 2 Diabetes
Diabetes Care,
January 1, 2004;
27(1):
223 - 228.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G.M. Hirschfield and M.B. Pepys
C-reactive protein and cardiovascular disease: new insights from an old molecule
QJM,
November 1, 2003;
96(11):
793 - 807.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Karvonen, M. Paivansalo, Y. A. Kesaniemi, and S. Horkko
Immunoglobulin M Type of Autoantibodies to Oxidized Low-Density Lipoprotein Has an Inverse Relation to Carotid Artery Atherosclerosis
Circulation,
October 28, 2003;
108(17):
2107 - 2112.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Turk, J. A. Carroll, M. H. Laughlin, T. R. Thomas, J. Casati, D. K. Bowles, and M. Sturek
C-reactive protein correlates with macrophage accumulation in coronary arteries of hypercholesterolemic pigs
J Appl Physiol,
September 1, 2003;
95(3):
1301 - 1304.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. S. Ford, A. H. Mokdad, W. H. Giles, and D. W. Brown
The Metabolic Syndrome and Antioxidant Concentrations: Findings From the Third National Health and Nutrition Examination Survey
Diabetes,
September 1, 2003;
52(9):
2346 - 2352.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. C.B. Tan, N. M.S. Wat, S. C.F. Tam, E. D. Janus, T.H. Lam, and K. S.L. Lam
C-Reactive Protein Predicts the Deterioration of Glycemia in Chinese Subjects With Impaired Glucose Tolerance
Diabetes Care,
August 1, 2003;
26(8):
2323 - 2328.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. T. Schram, N. Chaturvedi, C. Schalkwijk, F. Giorgino, P. Ebeling, J. H. Fuller, and C. D. Stehouwer
Vascular Risk Factors and Markers of Endothelial Function as Determinants of Inflammatory Markers in Type 1 Diabetes: The EURODIAB Prospective Complications Study
Diabetes Care,
July 1, 2003;
26(7):
2165 - 2173.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Sartipy and D. J. Loskutoff
Monocyte chemoattractant protein 1 in obesity and insulin resistance
PNAS,
June 10, 2003;
100(12):
7265 - 7270.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Varo, D. Vicent, P. Libby, R. Nuzzo, A. L. Calle-Pascual, M. R. Bernal, A. Fernandez-Cruz, A. Veves, P. Jarolim, J. J. Varo, et al.
Elevated Plasma Levels of the Atherogenic Mediator Soluble CD40 Ligand in Diabetic Patients: A Novel Target of Thiazolidinediones
Circulation,
June 3, 2003;
107(21):
2664 - 2669.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. D. Slade, E. M. Ghezzi, G. Heiss, J. D. Beck, E. Riche, and S. Offenbacher
Relationship Between Periodontal Disease and C-Reactive Protein Among Adults in the Atherosclerosis Risk in Communities Study
Arch Intern Med,
May 26, 2003;
163(10):
1172 - 1179.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. E. King, A. G. Mainous III, T. A. Buchanan, and W. S. Pearson
C-Reactive Protein and Glycemic Control in Adults With Diabetes
Diabetes Care,
May 1, 2003;
26(5):
1535 - 1539.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Wolf, L. Sandler, K. Hsu, K. Vossen-Smirnakis, J. L. Ecker, and R. Thadhani
First-Trimester C-Reactive Protein and Subsequent Gestational Diabetes
Diabetes Care,
March 1, 2003;
26(3):
819 - 824.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. A. Pearson, G. A. Mensah, R. W. Alexander, J. L. Anderson, R. O. Cannon III, M. Criqui, Y. Y. Fadl, S. P. Fortmann, Y. Hong, G. L. Myers, et al.
Markers of Inflammation and Cardiovascular Disease: Application to C | |